Skip to main
ADUS
ADUS logo

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 60%
Hold 0%
Sell 7%
Strong Sell 0%

Bulls say

Addus HomeCare Corp is positioned for a positive financial outlook, primarily driven by robust growth in its Hospice segment, which is projected to expand at the high end of 5-7% due to strong rate increases and improved admissions. Additionally, the company has experienced a 5.6% year-over-year increase in hospice revenue per patient day and anticipates a stable growth rate of 3-5% in Personal Care Services revenue for 2025, supported by the normalization of admissions and efficient management of its case load. Furthermore, updated revenue estimates reflect significant upward revisions in consensus estimates, signaling an overall optimistic outlook for Addus HomeCare's financial performance as it explores various merger and acquisition opportunities to enhance its service offerings.

Bears say

Addus HomeCare Corp's negative outlook is primarily influenced by a decline in its Home Health segment, which experienced a 3.2% year-over-year decrease in volumes and a 6.2% drop in new admissions, contributing to revenues falling 2.7% below expectations. Additionally, the anticipated decrease in average hourly rates within its Personal Care Services segment and an overall compression in gross margins, projected at approximately 200 basis points, highlight ongoing challenges in cost management and revenue generation. Furthermore, lowered adjusted EBITDA estimates for 2025 to 2027 indicate a deteriorating financial forecast, with growth expectations being revised downward, signaling potential ongoing underperformance in the company's financial health.

Addus HomeCare (ADUS) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 15 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Aug 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $118.13, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $118.13, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.